Schwarz Dygos Wheeler Investment Advisors LLC Buys 228 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Schwarz Dygos Wheeler Investment Advisors LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 5.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,109 shares of the company’s stock after purchasing an additional 228 shares during the period. Schwarz Dygos Wheeler Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $318,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. First Command Advisory Services Inc. grew its holdings in GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after buying an additional 369 shares in the last quarter. Legacy Financial Group LLC acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at $26,000. OFI Invest Asset Management acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth $26,000. ORG Partners LLC grew its holdings in shares of GE HealthCare Technologies by 174.2% during the 3rd quarter. ORG Partners LLC now owns 425 shares of the company’s stock worth $29,000 after purchasing an additional 270 shares in the last quarter. Finally, Fortitude Family Office LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $29,000. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on GEHC shares. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their target price for the stock from $66.00 to $88.00 in a report on Monday, February 12th. HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective on the stock. Mizuho raised their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. Evercore ISI raised their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Finally, Citigroup raised their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $95.09.

Check Out Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Trading Up 0.3 %

Shares of GEHC traded up $0.29 during mid-day trading on Friday, reaching $86.24. 1,790,728 shares of the company were exchanged, compared to its average volume of 2,231,738. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The stock has a market capitalization of $39.35 billion, a PE ratio of 28.56, a PEG ratio of 2.99 and a beta of 0.94. The business has a 50 day simple moving average of $88.92 and a two-hundred day simple moving average of $78.45.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same period last year, the company earned $1.31 earnings per share. The firm’s revenue was up 5.3% compared to the same quarter last year. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s payout ratio is currently 3.97%.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.